Viewing nowCMG Rosuvastatin Tablet 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201402642 · Approved 2014.06.12 · Insurance code 648602680
Improvement of dyslipidemia, prevention of cardiovascular disease, and inhibition of atherosclerosis progression
This medication is used as an adjunct when dietary measures and exercise are insufficient for patients with primary hypercholesterolemia and mixed dyslipidemia. It is also used as an adjunct in patients with homozygous familial hypercholesterolemia alongside other lipid-lowering therapies. It helps lower total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. It can be used as a dietary adjunct for pediatric patients with heterozygous familial hypercholesterolemia who exceed certain criteria, and it is also suitable as a dietary adjunct for patients with primary dysbetalipoproteinemia. Moreover, it assists in reducing the risk of stroke, myocardial infarction, and vascular revascularization in adults at high risk for cardiovascular disease. Thus, it is effectively used for various types of dyslipidemias and the reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed when the Child-Pugh score was 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Aged 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses above 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Younger than 10 years: Safety and efficacy have not been established in children younger than 10 years.
This medication should not be used in certain patients. For instance, patients with allergies to its components, those with severe hepatic impairment, patients with muscular diseases, patients taking certain immunosuppressants, those with severe renal impairment, women who are pregnant or breastfeeding, and women of childbearing age who are not using appropriate contraception should not take this medication. Additionally, high-dose administration is prohibited in patients at risk for muscular diseases, and this medication contains lactose, so patients with genetic issues such as lactose intolerance should also avoid it. Before taking this medication, regular liver function tests and muscle-related tests should be conducted, and caution is required for patients who consume excessive alcohol or have a history of liver disease. Symptoms such as muscle pain, muscle weakness, fatigue, and fever should be reported to a physician immediately, and in severe cases, medication discontinuation may be necessary. This medication may interact with other drugs, so if you are currently taking any medication, be sure to inform your doctor or pharmacist. Particular caution should be observed when taken with certain antiviral drugs, immunosuppressants, antifungals, certain antibiotics, and fibrate drugs as the risk of muscular diseases may increase. Women who are pregnant or may become pregnant should not take this medication, and if pregnancy is confirmed while on this medication, it should be stopped immediately. It is also recommended that breastfeeding women refrain from taking this medication. There is no specific antidote for overdose, so treatment will depend on the symptoms, and liver function and muscle enzyme testing will be necessary. This medication is known not to significantly affect driving or machine operating abilities, however, caution is advised as dizziness may occur. Lastly, this medication may show higher blood concentration levels in Asians, thus dosage adjustments may be needed.
Hypersensitivity reactions including angioedema, diabetes, headaches, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized body pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, thus it should be stored in a tightly sealed container. Moreover, it is best kept at room temperature between 1°C and 30°C, avoiding extremes of heat or cold.
Yellow round film-coated tablet
30 tablets (15 tablets/PTP x 2 packs), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.